Melanoma drug shrinks brain metastases in phase I/II study
Tuesday, October 12, 2010 - 10:03
in Health & Medicine
A new drug being developed to treat potentially deadly melanoma skin cancers has shown a promising ability to shrink secondary tumors, known as metastases, in the brain in patients with advanced forms of the disease, Australian researchers report.